Division News

Medicine Grand Rounds on Fri., March 21 at 8 a.m. in Duke Hospital room 2002 will feature Kimberly Blackwell, MD, professor of medicine (Medical Oncology). Dr.

Steven Patierno, PhD, professor of medicine (Medical Oncology) and deputy director of the Duke Cancer Institute, will receive $830,000 in grant funding from the Department of Defense to support his study of the Validation and Interrogation of Differentially Expressed and Alternatively Spliced Genes in African-American Prostate Cancer. "This is a great testament to the collaborati

The Duke Institute for Health Innovation will fund two new, collaborative faculty projects that aim to improve care for breast cancer patients and individuals undergoing stem cell transplants. The projects are the first to be funded by Duke's new multidisciplinary institute that promotes innovation in health care through research, leadership development and entrepreneurship.

Duke University and the University of Colorado schools of medicine have received a $10 million grant from the National Institute for Nursing Research (NINR), part of the National Institutes of Health, to continue development of the Palliative Care Research Cooperative Group over the next five years.

The Duke Cancer Institute has announced that Hope E. Uronis, MD, MHS, associate professor of medicine (Medical Onocology), will be DCI's associate clinical director. In this capacity, Dr.

The Duke Cancer Institute (DCI) is pleased to announce the first round of funding for the Cancer Survivorship Center pilot research projects.

This weekend a number of Department of Medicine faculty and trainees will be participating in the American Society of Clinical Oncology's Quality Care Symposium, which brings together leaders in the field to share new strategies, methods, and technologies for measuring and improving the quality of cancer care. Here's a list of those who will be representing Duke:

• "Developing a virtual collaborative to facilitate palliative care and quality improvement learning in oncology." Kamal, McNiff, Prestrud, Lupu, Zafar, Gavigan, Schilsky, Abernethy.

Peter Ubel, MD, professor of business administration, medicine and public policy; Amy Abernethy, MD, PhD, associate professor of medicine (Medical Oncology); and Yousuf Zafar, MD, MHS, assistant professor of medicine (Medical Oncology), have an article in this week's New England Journal of Medicine that looks at disclosing the financial consequences of treatments to patients.

[caption id="attachment_13367" align="alignright" width="175"] Charles S. Fuchs, MD, MPH[/caption] Medicine Grand Rounds on Fri., Oct. 11 at 8 a.m.

Amy Abernethy, MD, associate professor medicine (Medical Oncology) and director of the Duke Cancer Care Research Program and Center for Learning Health Care, was named one of the 30 most influential leaders in hospice and palliative medicine by the Amer